News InterCure Ltd.

Equities

INCR

IL0011063760

Healthcare Facilities & Services

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 08:06:05 16/04/2026 BST			5-day change	1st Jan Change
228.00 ^ILa	-1.17%		-3.63%	-29.54%

03-03	InterCure Receives Noncompliance Notice From Nasdaq	MT
03-03	InterCure receives Nasdaq notification regarding minimum bid requirement	RE

All News

03-03	InterCure Receives Noncompliance Notice From Nasdaq	MT
03-03	InterCure receives Nasdaq notification regarding minimum bid requirement	RE
03-03	InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement	AQ
02-19	InterCure announces preliminary estimated 2025 revenue of NIS 265 million, positive adjusted EBITDA and cash of NIS 43 million	RE
02-19	InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million	AQ
12-18	InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court	RE
11-03	Cannasoul Analytics Ltd. announced that it expects to receive funding from InterCure Ltd.	CI
11-03	InterCure Ltd. Enters into A Collaboration Agreement with Cannasoul R&D Ltd	CI
11-03	InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation	AQ
08/10/25	InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
08/10/25	Intercure reports first half 2025 results with NIS 130 million in revenue and positive operating cash flow	RE
08/10/25	InterCure Ltd H1 2025 revenue NIS 130 million	RE
08/10/25	InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow	AQ
19/09/25	Sector Update: Health Care Stocks Mixed Late Afternoon	MT
19/09/25	InterCure to Acquire Cannabis Brand Botanico in Two-Phase Deal	MT
19/09/25	Intercure to buy ISHI, gaining access to premium U.S. cannabis tech and brands	RE
19/09/25	InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands	AQ
18/09/25	InterCure Ltd. agreed to acquire Botanico Ltd. for ILS 25.3 million.	CI
01/05/25	InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025	PR
01/05/25	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
12/02/25	Intercure Names Announces Board Changes, Effective February 13, 2025	CI
12/02/25	InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak	PR
03/02/25	InterCure : Immediate Report	PU
02/02/25	InterCure : A meeting to be held on February 3, 2025-Amendment regarding the private placement	PU
27/01/25	InterCure : Immediate Report	PU